HCA Healthcare is set to drop its Q2 earnings this Friday, with analysts expecting a 6.2% revenue jump—nearly matching last year’s 6.4% growth. While the company’s stock has lagged peers in recent weeks, its average price target remains strong at $467.60. Investors will be watching closely as HCA tries to rebound after missing targets in recent quarters, especially as competitors like UnitedHealth and Elevance Health delivered mixed results—boosting or dragging their stocks accordingly.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
